Health Care & Life Sciences » Biotechnology | Human Metabolome Technologies Inc.

Human Metabolome Technologies Inc. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
1,509
1,463
1,253
1,620
1,462
1,104
Total Accounts Receivable
122
106
153
167
220
206
Inventories
10
12
26
23
27
37
Other Current Assets
15
19
11
24
54
28
Total Current Assets
1,657
1,601
1,443
1,835
1,763
1,376
Net Property, Plant & Equipment
84
130
91
72
140
220
Total Investments and Advances
-
-
102
101
-
-
Intangible Assets
7
5
3
4
9
12
Other Assets
12
6
11
10
10
12
Total Assets
1,759
1,741
1,650
2,022
1,921
1,621
ST Debt & Current Portion LT Debt
81
37
25
3
9
Accounts Payable
-
-
-
7
-
Income Tax Payable
10
4
8
35
8
Other Current Liabilities
55
57
68
108
105
Total Current Liabilities
146
104
101
146
122
Long-Term Debt
55
31
6
-
32
Provision for Risks & Charges
10
12
14
14
14
Deferred Taxes
1
10
6
3
1
Other Liabilities
-
2
1
-
-
Total Liabilities
211
158
126
163
169
Common Equity (Total)
1,548
1,583
1,523
1,859
1,753
Total Shareholders' Equity
1,548
1,583
1,523
1,859
1,753
Total Equity
1,548
1,583
1,523
1,859
1,753
Liabilities & Shareholders' Equity
1,759
1,741
1,650
2,022
1,921

About Human Metabolome Technologies

View Profile
Address
246-2 Mizukami, Kakuganji
Tsuruoka Yamagata 997
Japan
Employees -
Website http://humanmetabolome.com
Updated 07/08/2019
Human Metabolome Technologies, Inc. engages in diagnostic technology and medical products. Its operations are carried out through the following segments: Metabolome Analysis, Biomarker, and Temporary Staffing. The Metabolome Analysis segment provides contract analysis service based on the metabolome analysis on measured samples from the clients.